Select a section from the left sidebar
Primulagenin A
- Family: Plantae - Myrsinaceae
- Kingdom: Plantae
-
Class: Terpenoid
- Subclass: Pentacyclic Triterpenoid
Canonical Smiles | OC[C@@]12CCC(C[C@H]2C2=CC[C@H]3[C@@]([C@@]2(C[C@H]1O)C)(C)CC[C@@H]1[C@]3(C)CC[C@@H](C1(C)C)O)(C)C |
---|---|
InChI | InChI=1S/C30H50O3/c1-25(2)14-15-30(18-31)20(16-25)19-8-9-22-27(5)12-11-23(32)26(3,4)21(27)10-13-28(22,6)29(19,7)17-24(30)33/h8,20-24,31-33H,9-18H2,1-7H3/t20-,21-,22+,23-,24+,27-,28+,29+,30+/m0/s1 |
InChIKey | YHGVYECWZWIVJC-TVZJSHMMSA-N |
Formula | C30H50O3 |
HBA | 3 |
HBD | 3 |
MW | 458.73 |
Rotatable Bonds | 1 |
TPSA | 60.69 |
LogP | 6.11 |
Number Rings | 5 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Fraction CSP3 | 0.93 |
Exact Mass | 458.38 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Embelia schimperi | Myrsinaceae | Plantae | 2595069 |
Showing of synonyms
Primulagenin A
Genin A
465-95-2
UNII-55Z6ND22N6
CHEBI:70978
55Z6ND22N6
SCHIWALLIGENIN B1
GENIN A (PRIMULA)
3beta,16alpha,28-trihydroxy-12-oleanene
(3beta,16alpha)-olean-12-ene-3,16,28-triol
Olean-12-ene-3,16,28-triol, (3beta,16alpha)-
OLEAN-12-ENE-3beta,16alpha,28-TRIOL
Primulagenin
(3S,4aR,6aR,6bS,8R,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,8-diol
CHEMBL496854
SCHEMBL1050073
BDBM50480252
HY-N12211
DA-77059
CS-0895457
OLEAN-12-ENE-3.BETA.,16.ALPHA.,28-TRIOL
Q27139226
OLEAN-12-ENE-3,16,28-TRIOL, (3.BETA.,16.ALPHA.)-
Pubchem:
10004345
Cas:
465-95-2
Zinc:
ZINC000034073896
Chebi:
70978
Nmrshiftdb2:
60069062
Chembl:
CHEMBL496854
Bindingdb:
50480252
No compound-protein relationship available.
SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5
Level: 0
Mol. Weight: 458.73 g/mol
Antibacterial
Absorption
- Caco-2 (logPapp)
- -4.79
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.6
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -2.52
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.43
- Plasma Protein Binding
- 82.02
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 11.41
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -0.83
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 0.75
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 6.03
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Toxic
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Toxic
- T. Pyriformis
- -83.4
- Rat (Acute)
- 2.43
- Rat (Chronic Oral)
- 1.99
- Fathead Minnow
- 3.85
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 423.17
- Hydration Free Energy
- -2.78
- Log(D) at pH=7.4
- 5.85
- Log(P)
- 6.27
- Log S
- -6.07
- Log(Vapor Pressure)
- -8.96
- Melting Point
- 267.62
- pKa Acid
- 11.08
- pKa Basic
- 7.75
No predicted protein targets found for this compound.